Steven Fakharzadeh

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An Outcome Instrument for Cutaneous Lupus Erythematosus

Joerg Albrecht, Lynne Taylor, Jesse A. Berlin et al. · Journal of Investigative Dermatology · 2005 · 487 citations · Full text

Autoimmune Disease, Systemic Lupus Erythematosus Treatment, Lupus +7

Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis

Robert E. Kalb, David Fiorentino, Mark Lebwohl et al. · JAMA Dermatology · 2015 · 364 citations

Risk of malignancy with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment Registry

David Fiorentino, Vincent Ho, Mark Lebwohl et al. · Journal of the American Academy of Dermatology · 2017 · 156 citations · Full text

Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): Results from analyses of infections and malignancy from pooled phase II and III clinical trials

Kenneth B. Gordon, Kim Papp, Richard G. Langley et al. · Journal of the American Academy of Dermatology · 2011 · 140 citations

Medicine, Severe Psoriasis, Immunology +6

Protection against Pemphigus Foliaceus by Desmoglein 3 in Neonates

Hong Wu, Zhi Hong Wang, Albert C. Yan et al. · New England Journal of Medicine · 2000 · 128 citations · Full text

Antiparasitic Agent, Pathology, Pemphigus Foliaceus +16